• 1-myristoylglycerophosphocholine Assay Guide

  2026-08-11

  Build defined lysophospholipid experiments for fibroblast activation, epithelial lipid transfer, and smooth muscle function. This workflow combines concentration-response design, lipidomics-aware controls, and practical handling guidance for 14:0 Lyso-PC.

• Reelin–SFK Signaling in Ketamine Antidepressant Action

  2026-08-10

  The reference study identifies intact Reelin–Apoer2–Src family kinase signaling as a permissive requirement for ketamine-induced hippocampal synaptic plasticity and antidepressant-like behavioral effects in mice. Its genetic and pharmacological experiments suggest that impaired baseline NMDA receptor function, rather than a simple failure of ketamine to alter downstream phosphorylation, may contribute to nonresponsiveness.

• M344: Reliable HDAC Assay Design

  2026-08-09

  This scenario-driven guide explains how M344 (SKU A4105) can support interpretable viability, proliferation, differentiation, and apoptosis workflows. It connects documented potency and handling data with practical decisions about dosing, solvent control, assay compatibility, and vendor reliability.

• Dihydroethidium (DHE): Superoxide Assay Guide

  2026-08-08

  Dihydroethidium, also called hydroethidine, is a cell-permeable fluorescent probe used for relative intracellular superoxide measurement. Reliable interpretation requires separating superoxide-derived 2-hydroxyethidium from nonspecific ethidium formation and validating red fluorescence with appropriate controls.

• MK-2206 dihydrochloride: Assay Guide

  2026-08-07

  A scenario-driven guide to using MK-2206 dihydrochloride (SKU A3010) in viability, proliferation, apoptosis, and PI3K/Akt/mTOR pathway experiments. It covers dose interpretation, solvent compatibility, orthogonal readouts, and practical vendor-selection criteria for more defensible laboratory decisions.

• Moesin as a Biomarker of Sepsis-Induced Endothelial Injury

  2026-08-07

  This study establishes moesin (MSN) as a novel serum biomarker for endothelial injury severity in sepsis, showing its mechanistic role in vascular permeability and inflammation. The findings provide new avenues for evaluating sepsis progression and targeting endothelial dysfunction in translational research.

• Z-VAD-FMK in Translational Apoptosis Research: Mechanisms &

  2026-08-06

  This thought-leadership article explores how Z-VAD-FMK, an irreversible pan-caspase inhibitor, advances translational apoptosis research. It provides mechanistic context, practical workflow strategies, and cross-compares emerging evidence from cancer models to inform pathway dissection and therapeutic development.

• Phosbind Biotin: Dinuclear Metal Complex for Phosphorylation

  2026-08-06

  Phosbind Biotin leverages dinuclear metal complex phosphate binding to offer sequence-independent, highly sensitive detection of phosphorylated proteins—streamlining Western Blot workflows and empowering advanced signal transduction research. Its robust performance as a phospho-specific antibody alternative unlocks new experimental flexibility across plant and biomedical studies.

• RNA Pol II Degradation Triggers Apoptosis Beyond Transcripti

  2026-08-05

  Harper et al. reveal that cell death following RNA Pol II inhibition is not due to passive loss of transcription but is actively signaled by the degradation of hypophosphorylated RNA Pol IIA, engaging a regulated apoptotic pathway. These findings challenge longstanding assumptions in DNA damage response research and inform new strategies for targeting transcriptional machinery in cancer biology.

• 3X (DYKDDDDK) Peptide: Mechanistic Insights and Translationa

  2026-08-05

  Explore how the 3X (DYKDDDDK) Peptide advances affinity purification, structural biology, and translational research strategy—integrating mechanistic, experimental, and clinical perspectives with evidence from cutting-edge lipid transport studies.

• T-5224 (C-Fos/AP-1 Inhibitor): Beyond Inflammation to Ferrop

  2026-08-04

  Discover how T-5224, a selective C-Fos/AP-1 inhibitor, advances research from arthritis and inflammation to ferroptosis and cancer cell death. This article reveals new mechanistic insights and practical guidance for leveraging T-5224 in complex disease models.

• iTBS Enhances Motor Function and Reduces Pathology in SCA3 M

  2026-08-04

  This study demonstrates that intermittent theta-burst stimulation (iTBS) significantly improves motor coordination and mitigates neuroinflammation and protein aggregation in a mouse model of spinocerebellar ataxia type 3 (SCA3/MJD). The findings highlight iTBS as a promising noninvasive intervention for modifying disease pathology and functional outcomes in SCA3.

• RapaLink-1: Third-Generation mTOR Inhibitor for Dormancy & C

  2026-08-03

  RapaLink-1, a third-generation mTOR inhibitor, delivers robust and durable pathway inhibition for both cancer and embryonic dormancy models. Its bivalent mechanism ensures efficacy where other inhibitors fail, enabling scalable, noninvasive assays and precise experimental control.

• PA-824: Molecular Insights and Next-Generation TB Assay Desi

  2026-08-03

  Explore the advanced molecular mechanisms of PA-824, a potent bicyclic nitroimidazole derivative, and discover how its unique properties can redefine tuberculosis research assay strategies. This article offers deep analysis and practical guidance not found elsewhere.

• Gepotidacin (GSK2140944): Protocols for Antibacterial Resear

  2026-08-02

  Gepotidacin (GSK2140944) is a breakthrough in antibacterial research, offering potent activity against multidrug-resistant pathogens via a novel DNA replication inhibition mechanism. This article details experimental workflows, troubleshooting strategies, and clinically translatable advantages for employing Gepotidacin in both in vitro and in vivo studies.

8113 records 5/541 page Previous Next 12345 下5页 Last page